搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按时间排序
按相关度排序
NJBIZ
2 小时
Pharma giants defend against high-stakes lawsuit over weight loss drugs
Novo Nordisk and Eli Lilly are facing scores of personal injury claims for allegedly failing to warn patients about side ...
6 小时
Diabetes and weight loss drugs shown to reduce alcohol-related hospitalizations, study finds
Ozempic, Wegovy and other GLP-1 drugs have been shown to curb alcoholism, a new study suggests. Researchers explain why ...
10 小时
on MSN
What RFK Jr. Has Said About Ozempic the Popular Weight Loss Drug
Kennedy Jr., who has been tapped by Trump to lead the HHS, has been critical of Ozempic and other weight loss drugs.
13 小时
RFK, Jr. would face a 'trifecta' of challenges in turning the tide on obesity epidemic ...
Fox News medical contributor Dr. Nicole Saphier said changing America's food system is "not going to be an easy fix" while ...
Knowridge
17 小时
Diabetes medication may help reduce alcohol consumption
A recent study from the University of Nottingham suggests that certain diabetes medications might help people drink less ...
19 小时
Doctors say RFK Jr.’s anti-Ozempic stance perpetuates stigma and misrepresents evidence
Robert F. Kennedy Jr. has pledged to tackle high rates of chronic diseases such as diabetes and obesity as President-elect ...
20 小时
Eli Lilly and Novo Want to Shake off Ozempic Copycats. Are They Ready to Meet Demand?
The makers of Ozempic and Zepbound are fighting to stop compounded copies of their drugs. But it’s unclear whether they can ...
1 天
The UK thinks weight loss drugs could ease unemployment. Experts say that’s a fantasy
In the United Kingdom, the government is hoping weight loss drugs might improve public finances, eyeing their use to help ...
TCTMD
1 天
SUMMIT: Tirzepatide a ‘Huge Win’ for HFpEF Patients With Obesity
HF specialists agree these drugs will be key tools in fighting the obesity-related HFpEF epidemic. Hurdles and questions ...
MedPage Today
1 天
Tirzepatide Officially Puts GLP-1 Meds on the Map for Obesity-Related Heart Failure
CHICAGO -- A long-acting GIP/GLP-1 receptor agonist conferred significant clinical benefit for people with obesity and ...
Medscape
1 天
Tirzepatide Reduces Heart Failure Events in HFpEF With Obesity
SUMMT has shown for the first time that a drug can reduce major heart failure clinical outcomes in patients with heart ...
The American Journal of Managed Care
1 天
For Obesity and HFpEF, Tirzepatide Cuts Risk of CV Death or Worsening HF by 38%
Payers and employers have tightened access to the glucagon-like peptide-1 receptor agonist class once these therapies became ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈